Bulletin
Investor Alert

New York Markets Close in:

Aug. 7, 2020, 2:10 a.m. EDT

Orphan Drugs Market | 2020 Industry Analysis By Size, Growth, Trends, Share, Opportunity, Key Players, COVID-19 Impact, New Developments and Regional Outlook With Global Forecast To 2027

Orphan Drugs Market 2020 Global Industry Forecast To 2027 is latest depth analysis research published by Fortune Business Insights. According to this report the Global Orphan Drugs Market size will rise from Covid-19 crisis at moderate growth rate during forecast period of 2020 to 2027. Report analyzes Orphan Drugs Market Information By Therapy Area (Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, and Others), By Drug Type (Biologics, and Non-Biologics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, and Others), and Regional Forecast, 2020-2027.

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Aug 07, 2020 (The Expresswire) -- Orphan Drugs Market 2020 Global Industry Forecast To 2027 is latest depth analysis research published by Fortune Business Insights. According to this report the Global Orphan Drugs Marketsize will rise from Covid-19 crisis at moderate growth rate during forecast period of 2020 to 2027. Report analyzes Orphan Drugs MarketInformation By Therapy Area (Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, and Others), By Drug Type (Biologics, and Non-Biologics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, and Others), and Regional Forecast, 2020-2027.

Orphan Drugs MarketResearch provides comprehensive information on Global Orphan Drugs Market trends, opportunity, market drivers, restraints, Industry Challenges, with new business strategies, insights on new developments by key companies involved in Orphan Drugs Market.

Key Players Analyzed In Report: Amgen Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Alexion Pharmaceuticals Inc., Novo Nordisk A/S, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc., Daiichi Sankyo Company Limited, GlaxoSmithKline plc.

Get Sample Report To Know How COVID-19 Impacting Orphan Drugs Market

Global Orphan Drugs Market Analysis:

The oncology segment is witnessing considerably high demand on account of the rising number of patients suffering from different types of cancers. This also increases the demand for novel therapeutics, which as per the report will bode well for the global orphan drugs market. According to the National Center for Health Statistics, the U.S. is likely to witness around 1,762,450 new cancer cases in 2019. Spurred by these numbers, the demand for orphan drugs is likely to increase in the coming years. Governments are investing heavily to build a strong framework for supporting drug development, thus offering a significant impetus to the orphan drugs market. Furthermore, the return on investment, with regards to orphan drugs, is expected to be higher than non-orphan drugs, which in turn is increasing the demand for orphan drug therapeutics worldwide.

“People across the world are becoming more aware about the rising prevalence of rare disorders and importance of orphan drugs,” stated a lead analyst at Fortune Business insights. “This, coupled with robust support from EU and FDA to drug development, drives the orphan drugs market,” he added. Several pharma companies are also putting continuous efforts to develop orphan drugs, thus improving creating scope for generating more revenue in the overall global market for orphan drugs.

Oncology Segment to Exhibit Considerably High Demand for Orphan Drugs

The demand for oncology orphan drugs is increasing mainly on account of rising prevalence of cancer. Also, increasing number of FDA approvals for oncology orphan drugs is expected to drive the oncology therapy segment. Increased EU approvals are likely to pave way for the entry of novel orphan drugs during the forecast period. The oncology area is facing tremendous pressure as majority of patients are diagnosed with cancer every year. Moreover, different types of rare cancers have been discovered over the past few years, which calls for an immediate need to implement the administration of complex orphan drugs. Fortune Business Insights in the report predicts that this segment covered a share of 49.8% in the global orphan drugs market.

“The demand for specific orphan drugs is likely to increase as patients are becoming aware about the prevalent rare diseseses,” stated a lead analyst at Fortune Business Insights. “As a result of this, demand for orphan drugs is expected to increase in hospital pharmacies across the world,” he added. Rising RandD investments for drug development is another factor encouraging growth in the global orphan drugs market. Governments across the globe are developing a framework for drug development and discovery. This is expected to give significant impetus to the market in the forecast years.

Regional Market Overview:

Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2024, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

  • North America (United States, Canada and Mexico)

  • Europe (Germany, France, UK, Russia and Italy)

  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

  • South America (Brazil, Argentina, Colombia etc.)

  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

The global orphan drugs market is anticipated to pave way for the entry of several new players in the coming years. This is mainly because of the rapid drug development and discovery over the years. Several leading companies are manufacturing orphan drugs to build a nimble and agile framework. Some of the savvy players present in the global orphan drugs market are Actelion Pharmaceuticals Ltd., Biogen, Eli Lilly and Company, Bayer AG, Amgen Inc., and Pfizer Inc. These leading players are likely to give tough competition to the small entrants. Therefore, these small scale companies may need support from governments and other authorities to sustain in the market.

The report analyzes the ongoing market trends across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these regions, the market in North America currently holds the largest Orphan Drugs market share. The high prevalence of skin cancer in the United States is a major factor that has contributed to the growth of the regional market. The emphasis of major companies on introducing innovative treatment options and drugs will aid the growth of the market in the coming years.

Competitive Analysis:

The Orphan Drugs Market report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter's five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.

Intended Audience:

  • Orphan Drugs Key Players

  • Orphan Drugs Suppliers

  • Research and Development (RandD) Companies

  • Distributer and Supplier companies

  • End Users

  • Consultants and Investment bankers

  • Government as well as Independent Regulatory Authorities

Table of Content:

Report Introduction

Market Introduction

  • Definition

  • Scope Of The Study

  • Research Objective

  • Assumptions

  • Limitations

Research Methodology

  • Introduction

  • Primary Research

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.